Overview

LORATADINE SOFT GEL CAPSULES Strength. It is listed in the Health Canada Drug Product Database under DIN 02379481, held by APOTEX INC 150 Signet Drive Toronto Ontario Canada M9L 1T9, supplied as Capsule for Oral administration. Nexara Health is a licensed Canadian wholesale distributor and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.

Product details

Indications

LORATADINE SOFT GEL CAPSULES are indicated for: • the relief of symptoms associated with seasonal and perennial allergic rhinitis, such as sneezing, nasal discharge and itching, and ocular itching and burning. • the relief of symptoms and signs of chronic urticaria and other allergic dermatologic disorders.

Dosage and administration

Adults and Children 12+: 10 mg once daily. Patients with severe liver impairment: 10 mg every other day for adults and children >30kg.

Contraindications

Hypersensitivity to loratadine, descarboethoxy-loratadine, or any ingredient in the formulation or component of the container.

Warnings and precautions

Dosing adjustment recommended for severe liver disease. Use with caution in severe renal insufficiency. Not recommended for pregnant or lactating women.

Storage and handling

Store at room temperature 15°C to 30°C. Protect from exposure to excessive moisture.

Packaging

blisters of 12, 18, 20, 24, 30, 36, 48 and 72 capsules, packaged in a carton

Alternatives in the same therapeutic class

Products sharing ATC code R06AX13 LORATADINE. Marketed products are listed first. Substitution decisions rest with the prescriber or pharmacist, and interchangeability is determined provincially.